drugset / Trial / NCT00175955
Levetiracetam in the Treatment of Neuroleptic-induced Tardive Dyskinesia
RandomizedParallel-groupDouble-blind
Summary
An 8-week study to examine safety and efficacy of levetiracetam in patients with neuroleptic-induced tardive dyskinesia
Timeline
- Start
- 2005-05
- Primary completion
- 2005-12
- Completion
- 2005-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Levetiracetam | Other / unclassified | 3000 mg | Oral |